Lonestar Heart
LoneStar Heart, Inc. - Home
About Lonestar Heart
Lone Star Heart Inc. operates in the biotechnology sector, focusing on the development and commercialization of Selective Androgen Receptor Modulators (SARMs). These compounds are designed to target specific androgen receptors in the body, promoting muscle growth and bone health without the adverse side effects commonly associated with steroids. The company primarily serves fitness enthusiasts, athletes, and individuals suffering from muscle-wasting diseases. Lone Star Heart Inc.'s business model revolves around research and development, followed by the sale of SARMs products through various distribution channels, including online platforms and specialized health stores. Revenue is generated through direct sales and partnerships with healthcare providers. The market for SARMs is growing, driven by increasing awareness of their benefits and a rising demand for safer performance-enhancing alternatives.
Source: Dealroom company dataAt a glance
- Founded
- 2009
- Headquarters
- Laguna Hills, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lonestar Heart on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lonestar Heart on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.